TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 118 filers reported holding TRICIDA INC in Q3 2020. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,868 | -100.0% | 25,300 | -96.6% | 0.00% | -100.0% |
| Q3 2022 | $7,898,000 | +684.3% | 753,600 | +624.6% | 0.20% | +629.6% |
| Q2 2022 | $1,007,000 | +225.9% | 104,000 | +56.3% | 0.03% | +200.0% |
| Q3 2021 | $309,000 | -19.7% | 66,550 | -25.2% | 0.01% | -25.0% |
| Q2 2021 | $385,000 | -10.0% | 89,023 | +9.9% | 0.01% | -25.0% |
| Q1 2021 | $428,000 | -32.4% | 80,993 | -9.7% | 0.02% | -33.3% |
| Q4 2020 | $633,000 | +75.8% | 89,727 | +584.1% | 0.02% | -4.0% |
| Q2 2020 | $360,000 | +20.4% | 13,116 | -3.4% | 0.02% | 0.0% |
| Q1 2020 | $299,000 | -32.2% | 13,572 | -5.0% | 0.02% | -37.5% |
| Q3 2019 | $441,000 | -11.8% | 14,283 | +12.8% | 0.04% | -11.1% |
| Q2 2019 | $500,000 | -37.7% | 12,661 | -39.1% | 0.04% | -42.3% |
| Q1 2019 | $803,000 | – | 20,791 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |